8-K: Curis Faces Nasdaq Delisting, Plans Appeal

Curis, Inc. received a delisting notice from Nasdaq due to non-compliance with the minimum market value requirement and intends to appeal the decision.

Summary

• Curis, Inc. (CRIS) received a notice from Nasdaq on August 21, 2025, stating its securities would be delisted from The Nasdaq Capital Market.
• This delisting determination is due to the company's failure to regain compliance with Nasdaq Listing Rule 5550(b)(2), which requires a minimum market value of listed securities of $35,000,000.
• The company's market value had been below this threshold for 30 consecutive trading days, as initially disclosed on February 21, 2025.
• Curis was given a 180-calendar-day compliance period, which expired on August 20, 2025, but did not regain compliance.
• The company plans to appeal the delisting determination by requesting a hearing before the Nasdaq Hearings Panel by August 28, 2025.
• An appeal request will temporarily stay the suspension and delisting, allowing the common stock to continue trading on Nasdaq pending the Panel's decision.

Sentiment

Score: 3

Explanation: The filing indicates a significant negative event (delisting notice) but includes a plan for appeal, which offers a temporary stay and a chance for resolution, preventing a score of 1 or 2. However, the uncertainty of the appeal outcome and the underlying non-compliance are serious concerns.

Positives

• The company intends to appeal the delisting determination by requesting a hearing before the Nasdaq Hearings Panel.
• Requesting a hearing will stay the suspension and delisting of the company's securities, allowing them to remain listed and eligible for trading on Nasdaq pending the Panel's decision.

Negatives

• Received a notice from Nasdaq on August 21, 2025, stating that its securities would be delisted from The Nasdaq Capital Market.
• Failed to regain compliance with Nasdaq Listing Rule 5550(b)(2), which requires a minimum market value of listed securities of $35,000,000.
• The company's market value of listed securities had been below $35,000,000 for 30 consecutive trading days, as previously disclosed on February 21, 2025.

Risks

• There is no assurance that the company will ultimately regain compliance with Nasdaq listing requirements.
• There is no assurance that the company will remain listed on Nasdaq following the appeal process.
• Potential delisting from The Nasdaq Capital Market could negatively impact liquidity and investor confidence.

Future Outlook

The company intends to appeal Nasdaq's delisting determination, which will temporarily stay the delisting process. However, there is no guarantee that the company will ultimately regain compliance or remain listed on Nasdaq.

Management Comments

• The Company intends to make a timely request for a hearing before the Panel to appeal the Staffs determination.
• The Companys request for a hearing will stay the suspension and delisting of the Companys securities by the Staff pending the ultimate outcome of the hearing.
• The Companys common stock will remain listed and eligible for trading on Nasdaq pending the Panels decision; however, there can be no assurance that the Company will ultimately regain compliance and remain listed on Nasdaq.

Industry Context

For smaller public companies, maintaining listing compliance, particularly market value requirements, is a persistent challenge. Failure to meet these standards can lead to delisting, which often results in reduced stock liquidity, decreased investor visibility, and increased difficulty in raising capital. This situation is common among companies that experience prolonged periods of low stock performance or are in early development stages without significant revenue.

Comparison to Industry Standards

• Maintaining a minimum market value of listed securities, such as Nasdaq's $35,000,000 requirement, is a standard for public companies to ensure a certain level of investor interest and liquidity.
• Companies failing to meet these thresholds, like Curis, often face similar delisting notices.
• Many small-cap firms frequently navigate similar listing challenges, often requiring strategic actions like reverse stock splits or significant positive operational news to regain compliance.
• The process of appealing a delisting decision is also a standard procedure, offering a temporary stay and an opportunity to present a plan for compliance.

Stakeholder Impact

• Shareholders: Potential for reduced liquidity and investor confidence if delisted, and uncertainty regarding the company's future listing status.
• Employees: Potential impact on morale and future stability if the company faces significant operational or financial challenges due to delisting.
• Creditors: Potential increase in perceived risk, which could affect future financing terms.

Next Steps

• Submit a timely request for a hearing before the Nasdaq Hearings Panel by August 28, 2025.
• Present its case to the Panel to appeal the delisting determination.

Key Dates

Recommendation

The receipt of a delisting notice from Nasdaq, even with an intent to appeal, signals significant underlying issues with the company's market valuation and potentially its operational performance. While an appeal provides a temporary reprieve, the uncertainty of the outcome and the fundamental failure to meet listing requirements pose substantial risks to shareholders. The lack of assurance regarding future listing and the potential for reduced liquidity upon delisting make this a high-risk situation, warranting a sell recommendation for investors to mitigate further potential losses.

Keywords

Curis, CRIS, Nasdaq, Delisting, Listing Rule 5550(b)(2), Market Value, Compliance, Appeal